BUZZ-InspireMD rises after quarterly revenue beat ** Shares of medical device maker InspireMD NSPR.O rise 10.61% to $1.98
** Co posts Q4 revenue of $3.1 million, above analysts' average estimate of $2.6 million, according to data compiled by LSEG
** Says quarterly revenue rose on early U.S. uptake of CGuard Prime, its neck artery implant to help prevent stroke, and higher international demand for CGuard, its earlier version
** Expects FY26 revenue in the range of $13 million to $15 million vs. analysts' estimate of $14.6 million
** Posts Q4 loss of 14 cents per share, while analysts expected a loss of 19 cents per share
** NSPR shares down ~32% in 2025
(Reporting by Kunal Das in Bengaluru)
((Kunal.Das2@thomsonreuters.com;))
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.